Nearly 4 of every 5 infants in Italy born with SMA type 1 since the approval of disease-modifying therapies (DMTs) are alive, ...

Columnist Ari Anderson has set a goal for 2025: to multiply the chances of good things coming his way each time they happen.

An algorithm may help predict the risk of scoliosis in patients who have received disease-modifying SMA treatment, a study ...

Columnist Halsey Blocher, who lives with SMA, feels a sense of connection with a Christmas movie's depiction of a disabled princess.

The SMA Europe project has patients sharing their story of how SMA treatment affects their lives with goal of better access ...

Natalie Katz, MD, is an assistant professor of pediatrics in the division of neurology at Duke University and co-directs the Duke Children’s Neuromuscular Program, which provides comprehensive ...